These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 16764996)

  • 1. Turbulent urinary flow in the urethra could be a causal factor for benign prostatic hyperplasia.
    Martinez-Borges AR
    Med Hypotheses; 2006; 67(4):871-5. PubMed ID: 16764996
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The overlooked cause of benign prostatic hyperplasia: prostatic urethral angulation.
    Cho KS; Kim J; Choi YD; Kim JH; Hong SJ
    Med Hypotheses; 2008; 70(3):532-5. PubMed ID: 17761390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between prostatic urethral angle and urinary flow rate: its implication in benign prostatic hyperplasia pathogenesis.
    Cho KS; Kim JH; Kim DJ; Choi YD; Kim JH; Hong SJ
    Urology; 2008 May; 71(5):858-62. PubMed ID: 18343484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vascular resistance in the prostate evaluated by colour Doppler ultrasonography: is benign prostatic hyperplasia a vascular disease?
    Berger AP; Horninger W; Bektic J; Pelzer A; Spranger R; Bartsch G; Frauscher F
    BJU Int; 2006 Sep; 98(3):587-90. PubMed ID: 16796699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A study of the simulation model of the lower urinary tract for urodynamics--(the first report)--theoretical evaluation of hydrodynamic model].
    Ohnishi K; Okihara K; Tanaka T; Watanabe M; Hayami H; Ohe H; Watanabe H; Yokobori T; Sasaki S
    Hinyokika Kiyo; 1991 Oct; 37(10):1249-53. PubMed ID: 1721769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New urodynamic model to explain micturition disorders in benign prostatic hyperplasia patients. Pressure-flow relationships in collapsable tubes, hydraulic analysis of the urethra and evaluation of urethral resistance.
    Glemain P; Buzelin JM; Cordonnier JP
    Eur Urol; 1993; 24 Suppl 1():12-7. PubMed ID: 7687552
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urethral pressure reflectometry; a novel technique for simultaneous recording of pressure and cross-sectional area: a study of feasibility in the prostatic urethra.
    Aagaard M; Klarskov N; Sønksen J; Bagi P; Colstrup H; Lose G
    BJU Int; 2012 Oct; 110(8):1178-83. PubMed ID: 22416900
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of anthropometric measures with the presence and progression of benign prostatic hyperplasia.
    Burke JP; Rhodes T; Jacobson DJ; McGree ME; Roberts RO; Girman CJ; Lieber MM; Jacobsen SJ
    Am J Epidemiol; 2006 Jul; 164(1):41-6. PubMed ID: 16611664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Benign prostatic hyperplasia: age-related tissue-remodeling.
    Untergasser G; Madersbacher S; Berger P
    Exp Gerontol; 2005 Mar; 40(3):121-8. PubMed ID: 15763388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The origin and development of benign prostatic hyperplasia. An age-dependent process.
    Oesterling JE
    J Androl; 1991; 12(6):348-55. PubMed ID: 1722790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Benign prostatic hyperplasia. A review of diagnostic and treatment options.
    Pfeiffer GM; Giacomarra M
    Adv Nurse Pract; 1999 Apr; 7(4):31-6; quiz 37-8. PubMed ID: 10382383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors for lower urinary tract symptoms suggestive of benign prostatic hyperplasia in a community based population of healthy aging men: the Krimpen Study.
    Kok ET; Schouten BW; Bohnen AM; Groeneveld FP; Thomas S; Bosch JL
    J Urol; 2009 Feb; 181(2):710-6. PubMed ID: 19091352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urethral stent (Angiomed-Memotherm) implantation in high-risk patients with urinary retention.
    Uchikoba T; Horiuchi K; Satoh M; Oka F; Saitoh Y; Tsuboi N; Nishimura T
    Hinyokika Kiyo; 2005 Apr; 51(4):235-9. PubMed ID: 15912781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic and predictive value of voiding diary data versus prostate volume, maximal free urinary flow rate, and Abrams-Griffiths number in men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia.
    van Venrooij GE; van Melick HH; Eckhardt MD; Boon TA
    Urology; 2008 Mar; 71(3):469-74. PubMed ID: 18342189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modifiable risk factors for benign prostatic hyperplasia and lower urinary tract symptoms: new approaches to old problems.
    Parsons JK
    J Urol; 2007 Aug; 178(2):395-401. PubMed ID: 17561143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dynamic simulation and analysis of the influence of urethral morphological changes on urodynamics after benign prostatic hyperplasia surgery: A computational fluid dynamics study.
    Wang X; Liu P; Zhao S; Wang F; Li X; Wang L; Yan Y; Zou GA; Xu G
    Comput Methods Programs Biomed; 2024 Jan; 243():107915. PubMed ID: 37995487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical impact of tamsulosin on generic and symptom-specific quality of life for benign prostatic hyperplasia patients: using international prostate symptom score and Rand Medical Outcomes Study 36-item Health Survey.
    Suzuki H; Yano M; Awa Y; Nakatsu H; Egoshi K; Mikami K; Ota S; Okano T; Hamano S; Ohki T; Furuya Y; Ichikawa T
    Int J Urol; 2006 Sep; 13(9):1202-6. PubMed ID: 16984553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stress, hostility, and disease parameters of benign prostatic hyperplasia.
    Ullrich PM; Lutgendorf SK; Leserman J; Turesky DG; Kreder KJ
    Psychosom Med; 2005; 67(3):476-82. PubMed ID: 15911913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is there evidence of a relationship between benign prostatic hyperplasia and prostate cancer? Findings of a literature review.
    Alcaraz A; Hammerer P; Tubaro A; Schröder FH; Castro R
    Eur Urol; 2009 Apr; 55(4):864-73. PubMed ID: 19027219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Urethral stent (Memotherm) for the treatment of benign prostatic hyperplasia].
    Noda Y; Ujike T; Oka D; Takada S; Fujimoto N; Koide T
    Hinyokika Kiyo; 2003 Nov; 49(11):645-7. PubMed ID: 14719451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.